Literature DB >> 28179344

Carbohydrate Antigen 19-9 Predicts Synchronous Peritoneal Carcinomatosis in Patients with Colorectal Cancer.

Manabu Kaneko1,2, Soichiro Ishihara2, Koji Murono2, Kazuhito Sasaki2, Kensuke Otani2, Koji Yasuda2, Takeshi Nishikawa2, Toshiaki Tanaka2, Tomomichi Kiyomatsu2, Keisuke Hata2, Kazushige Kawai2, Hiroaki Nozawa2, Hiroshi Nakayama3, Toshiyuki Watanabe3, Shin Sasaki3, Toshiaki Watanabe2.   

Abstract

BACKGROUND: Colorectal cancer (CRC) with peritoneal carcinomatosis (PC) has the worst prognosis among all types of metastases, but is difficult to diagnose. This study investigated whether preoperative serum carbohydrate antigen (CA) 19-9 level can predict synchronous PC in patients with primary CRC. PATIENTS AND METHODS: The cases of 395 CRC patients who underwent primary lesion resection were retrospectively reviewed. Risk factors were evaluated by uni- and multivariate analyses from clinicopathological data.
RESULTS: In the univariate analysis, tumor invasion (p<0.001), lymph node and hematogenous metastases (p=0.037 and p<0.001, respectively), and elevated preoperative serum CA19-9 level (p<0.001) were associated with synchronous PC, and multiple regression analysis revealed that an elevated preoperative serum CA19-9 level was an independent risk factor for PC (odds ratio=5.03, 95% confidence interval=1.29-19.60, p=0.020).
CONCLUSION: Elevated preoperative serum CA 19-9 level may be useful in predicting synchronous PC in patients with CRC. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Carbohydrate antigen 19-9; colorectal cancer; peritoneal carcinomatosis; risk factor

Mesh:

Substances:

Year:  2017        PMID: 28179344     DOI: 10.21873/anticanres.11391

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.

Authors:  Nikolaos Vassos; Pompiliu Piso
Journal:  Curr Treat Options Oncol       Date:  2018-09-01

2.  Risk Factors for Synchronous Peritoneal Metastases in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuanxin Zhang; Xiusen Qin; Rui Luo; Hui Wang; Huaiming Wang; Hongzhi Luo
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

Review 3.  Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research.

Authors:  Foteini Stefania Koumpa; Diamantis Xylas; Maciej Konopka; Dieter Galea; Kirill Veselkov; Anthony Antoniou; Akash Mehta; Reza Mirnezami
Journal:  Gastroenterol Res Pract       Date:  2019-04-01       Impact factor: 2.260

4.  P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Zachary Zihui Yong; Grace Hwei Ching Tan; Nicholas Shannon; Claramae Chia; Melissa Ching Ching Teo
Journal:  World J Surg Oncol       Date:  2019-08-07       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.